Nationwide Clonazepam Recall Expanded Due to Labeling Errors

Endo, Inc. has issued a nationwide recall of Clonazepam Orally Disintegrating Tablets due to a labeling error that could lead to potentially fatal overdoses. The error, made by a third-party packager, involves incorrect strength and National Drug Code on some cartons, though the blister strips and tablets are correctly labeled. The mislabeled drugs pose a risk of life-threatening respiratory depression, especially for vulnerable patients. Consumers are advised to stop using the affected tablets and consult a doctor if they have taken the wrong dose.